Health care services provider Encompass Health (NYSE: EHC) will be reporting earnings this Wednesday after market close. Here’s what to look for.
Encompass Health beat analysts’ revenue expectations last quarter, reporting revenues of $1.59 billion, up 9% year on year. It was a satisfactory quarter for the company, with a beat of analysts’ EPS estimates.
Is Encompass Health a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Encompass Health’s revenue to grow 7.7% year on year, slowing from the 12% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Encompass Health has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Encompass Health’s peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Centene delivered year-on-year revenue growth of 9.9%, beating analysts’ expectations by 13.1%, and Tenet Healthcare reported revenues up 6.8%, topping estimates by 3.9%. Centene traded down 3.5% following the results while Tenet Healthcare was up 17.2%.
Read our full analysis of Centene’s results here and Tenet Healthcare’s results here.
Investors in the healthcare providers & services segment have had steady hands going into earnings, with share prices up 1.9% on average over the last month. Encompass Health is up 4.4% during the same time and is heading into earnings with an average analyst price target of $140.50 (compared to the current share price of $111.75).
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
